Elutia Inc (ELUT) Stock Price, Quote & News

Company Profile

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators; and CanGaroo, which mitigates complications derived from implantable electronic devices and shortcom...

Industry: Medical Devices

Sector: Healthcare

Phone: 240 247 1170

Fax: 408 734 2629

Website: elutia.com

Address:

12510 Prosperity Drive, Suite 370, Silver Spring, United States

CEOBuysDisclosures Nov. 27 at 12:05 AM

$ELUT CEO purchased 5,000 shares at $0.60 for a total of $3,000. Mills C Randal now owns 358,785 shares. https://ceo-buys.com

0 · Reply

Tradingpirate Nov. 26 at 10:43 PM

$ELUT CEO bought another 5K shares. He's loading the boat https://images.squarespace-cdn.com/content/v1/5f890a2f2cbb67264f8a2950/1634049352519-MPEHPAHJV7KTBYE51HAR/Mills+Headshot.jpg?format=1000w

1 · Reply

Dani_G_German Nov. 26 at 4:37 PM

$ELUT 📈 🚀

0 · Reply

Stock_Catcher Nov. 26 at 3:32 PM

$ELUT thin

0 · Reply

Streax Nov. 24 at 11:43 PM

$ELUT is anyone still here? Any upside?

0 · Reply

CEOBuysDisclosures Nov. 15 at 12:05 AM

$ELUT CEO purchased 13,500 shares at $0.75 for a total of $10,110. Mills C Randal now owns 353,785 shares. https://ceo-buys.com

0 · Reply

d_risk Nov. 12 at 10:12 PM

$ELUT - Elutia Inc. Class A Common Stock - 10Q - Updated Risk Factors ELUT flags heavy reliance on breast reconstruction biologics after cardiac device sale and warns of potential Nasdaq delisting risk from low share price; otherwise, no substantial changes. #Biologics #LowSharePrice #NasdaqDelistingRisk #CardiacDevices #BreastReconstruction 🟢 Added 🟠 Removed https://d-risk.ai/ELUT/10-Q/2025-11-12

0 · Reply

resistancebreakers Nov. 6 at 10:43 PM

$ELUT 🪖🫡☝️

0 · Reply

Greenpa Oct. 26 at 12:13 AM

$ELUT CEO grossly overstated revenue prospects for Elupro. I suspect ran into reimbursement problems. Maybe will be better if get approved breast product, but burned investors will need to get high comfort level as I suspect that base has been largely lost.

1 · Reply

Suffix Oct. 23 at 7:24 PM

$ELUT Back in at $.8986, this should have a good run incoming. That sale puts about $2.10 cash per share. Should be an easy 100%+ from these levels. We will see if the big money allows that.

1 · Reply

Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 5 weeks ago

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

Oct 23, 2025, 4:05 PM EDT - 7 weeks ago

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Oct 14, 2025, 4:05 PM EDT - 2 months ago

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

Oct 10, 2025, 8:00 AM EDT - 2 months ago

Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Oct 1, 2025, 8:41 AM EDT - 2 months ago

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Sep 16, 2025, 8:00 AM EDT - 3 months ago

Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation

Sep 9, 2025, 8:30 AM EDT - 3 months ago

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Sep 4, 2025, 8:00 AM EDT - 3 months ago

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange

Aug 27, 2025, 8:00 AM EDT - 3 months ago

Elutia to Participate in Upcoming Investor Conferences

Aug 14, 2025, 9:03 PM EDT - 4 months ago

Elutia Inc. (ELUT) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:05 PM EDT - 4 months ago

Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption

Jul 31, 2025, 4:05 PM EDT - 4 months ago

Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Jul 31, 2025, 8:00 AM EDT - 4 months ago

Dr. Michelle LeRoux Williams Earns Washington Business Journal's Medical Device Innovator Award

Jul 1, 2025, 8:00 AM EDT - 5 months ago

New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices

Jun 26, 2025, 8:00 AM EDT - 6 months ago

Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards

May 28, 2025, 8:00 AM EDT - 7 months ago

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method

May 11, 2025, 7:32 AM EDT - 7 months ago

Elutia Inc. (ELUT) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 7 months ago

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

May 1, 2025, 4:05 PM EDT - 8 months ago

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

May 1, 2025, 8:00 AM EDT - 8 months ago

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

Apr 22, 2025, 4:05 PM EDT - 8 months ago

Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29

Apr 21, 2025, 8:00 AM EDT - 8 months ago

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Apr 14, 2025, 8:00 AM EDT - 8 months ago

Elutia Confirms No Material Impact from Global Tariffs

Apr 2, 2025, 4:05 PM EDT - 9 months ago

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

Mar 27, 2025, 4:05 PM EDT - 9 months ago

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

Mar 25, 2025, 4:05 PM EDT - 9 months ago

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

Mar 6, 2025, 6:22 PM EST - 10 months ago

Elutia Inc. (ELUT) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 4:05 PM EST - 10 months ago

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

Feb 20, 2025, 4:05 PM EST - 10 months ago

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Feb 3, 2025, 6:30 AM EST - 11 months ago

Elutia Announces $15.0 Million Registered Direct Offering

Nov 14, 2024, 8:11 PM EST - 1 year ago

Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript

Oct 23, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices

Sep 6, 2024, 4:23 PM EDT - 1 year ago

Elutia Celebrates First Year

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD EUDA GDTC GOSS GOVX IMRN

Aug 10, 2024, 7:27 AM EDT - 1 year ago

Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

Jun 17, 2024, 8:01 AM EDT - 1 year ago

Elutia Announces $13.26 Million Registered Direct Offering

Jun 17, 2024, 8:00 AM EDT - 1 year ago

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

May 12, 2024, 12:21 PM EDT - 1 year ago

Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

Mar 7, 2024, 8:43 PM EST - 1 year ago

Elutia, Inc. (ELUT) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:05 PM EST - 1 year ago

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

Feb 22, 2024, 4:05 PM EST - 1 year ago

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Jan 10, 2024, 4:05 PM EST - 2 years ago

Elutia Regains Compliance with Nasdaq Listing Requirements

Nov 17, 2023, 12:30 PM EST - 2 years ago

Elutia, Inc. (ELUT) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 2 years ago

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

CEOBuysDisclosures Nov. 27 at 12:05 AM

$ELUT CEO purchased 5,000 shares at $0.60 for a total of $3,000. Mills C Randal now owns 358,785 shares. https://ceo-buys.com

0 · Reply

Tradingpirate Nov. 26 at 10:43 PM

$ELUT CEO bought another 5K shares. He's loading the boat https://images.squarespace-cdn.com/content/v1/5f890a2f2cbb67264f8a2950/1634049352519-MPEHPAHJV7KTBYE51HAR/Mills+Headshot.jpg?format=1000w

1 · Reply

Dani_G_German Nov. 26 at 4:37 PM

$ELUT 📈 🚀

0 · Reply

Stock_Catcher Nov. 26 at 3:32 PM

$ELUT thin

0 · Reply

Streax Nov. 24 at 11:43 PM

$ELUT is anyone still here? Any upside?

0 · Reply

CEOBuysDisclosures Nov. 15 at 12:05 AM

$ELUT CEO purchased 13,500 shares at $0.75 for a total of $10,110. Mills C Randal now owns 353,785 shares. https://ceo-buys.com

0 · Reply

d_risk Nov. 12 at 10:12 PM

0 · Reply

resistancebreakers Nov. 6 at 10:43 PM

$ELUT 🪖🫡☝️

0 · Reply

Greenpa Oct. 26 at 12:13 AM

1 · Reply

Suffix Oct. 23 at 7:24 PM

$ELUT Back in at $.8986, this should have a good run incoming. That sale puts about $2.10 cash per share. Should be an easy 100%+ from these levels. We will see if the big money allows that.

1 · Reply

3z_ Oct. 15 at 2:56 PM

$ELUT 70% ⏳

0 · Reply

Universal6999 Oct. 10 at 3:45 PM

$ELUT got out at 0.99 thank god .......

0 · Reply

Gunnar1 Oct. 10 at 1:50 PM

$ELUT Holding a small amount here. This can male a solid move IMO. But high risk.

0 · Reply

Money_never_sleep Oct. 10 at 1:44 PM

$ELUT $→2 very

0 · Reply

Universal6999 Oct. 8 at 10:58 AM

$ELUT this companie sucks no real good

0 · Reply

Whiskey1679 Oct. 7 at 9:38 PM

Whiskey's Penny Picks out tomorrow by 6:00 AM PDT!! See my Profile for today's WINNERS 🏆. Have a good rest of the day folks!! AH Gainers: $BCG $LBGJ $BURU $ELUT $OMI

0 · Reply